Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Chun Hwa Kim"'
Autor:
Min-Jin Kim, Sang-A Park, Chun Hwa Kim, So-Yeon Park, Jung-Shin Kim, Dae-Kee Kim, Jeong-Seok Nam, Yhun Yhong Sheen
Publikováno v:
Cellular Physiology and Biochemistry, Vol 38, Iss 2, Pp 571-588 (2016)
Background/Aims: Hypoxia is an environmental factor that aggravates liver fibrosis. HIF1α activates hepatic stellate cells (HSCs) and increases transforming growth factor-β (TGF-β) signaling and the epithelial mesenchymal transition (EMT), acceler
Externí odkaz:
https://doaj.org/article/aa1967a19fd447b5a3ed5d4bab9e9129
Autor:
So Ra Kim, Dae-Hoon Kim, Soo Hyun Park, Young Seok Kim, Chun Hwa Kim, Tae-Young Ha, Jin Yang, Jae-Keol Rhee
Publikováno v:
Journal of Diabetes Research, Vol 2013 (2013)
G-protein coupled receptor 119 (GPR119) has emerged as a promising new target for the treatment of type 2 diabetes mellitus. The expression of GPR119 on the pancreatic B cells and intestinal L cells provides a unique opportunity for a single drug to
Externí odkaz:
https://doaj.org/article/71e115a2010548aab03f8daacde70c94
Autor:
chun hwa Kim
Publikováno v:
The Research Society for the Korean Language Education. 15:35-60
Autor:
Doo-Young Kim, Daehoon Kim, Chun Hwa Kim, Myoungki Baek, Kyu Hwan Lee, Seung Jun Kang, Hyo Sun Choi, Hankyu Lee
Publikováno v:
Diabetes. 69
Glucagon-like peptide-1 (GLP-1) mediates antidiabetogenic effects through the GLP-1 receptor (GLP-1R), which is targeted for the treatment of type 2 diabetes. Currently, GLP-1R agonists comprise a growing class of agents that deliver unprecedented ef
Autor:
Jae Keol Rhee, Sun Hee Lee, Goeun Yang, Seung Jun Kang, Hyo Sun Choi, Doo-Young Kim, Daehoon Kim, Chun Hwa Kim, Kwan Soo Lim, Jin Yang, Min Ah Park
Publikováno v:
Diabetes. 67
The free fatty acid receptor 1 (FFAR1/GPR40) mediates fatty acid-dependent augmentation of glucose-induced insulin secretion (GIIS) in pancreatic β-cells. The objective of the studies described here was to examine the pharmacological properties of H
Autor:
Jae Keol Rhee, Seung Jun Kang, Goeun Yang, Sun Hee Lee, Hyo Sun Choi, Chun Hwa Kim, Kwan Soo Lim, Min Ah Park, Doo-Young Kim, Daehoon Kim
Publikováno v:
Diabetes. 67
GPR40 is known as free fatty acid receptor 1. Currently, HD-6277, a novel GPR40 agonist, is being developed by Hyundai Pharm in first in human study. The aim of this study was to determine the effects of the novel GPR40 agonist. HD-6277 is a highly p
Autor:
Chun Hwa Kim, Min-Jin Kim, Dae-Kee Kim, Jeong-Seok Nam, Jung-Shin Kim, Yhun Yhong Sheen, So-Yeon Park, Sang-A Park
Publikováno v:
Cellular Physiology and Biochemistry, Vol 38, Iss 2, Pp 571-588 (2016)
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY(38): 2
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY(38): 2
Background/Aims: Hypoxia is an environmental factor that aggravates liver fibrosis. HIF1 alpha activates hepatic stellate cells (HSCs) and increases transforming growth factor-beta (TGF-beta) signaling and the epithelial mesenchymal transition (EMT),
Autor:
Eung-Seok Lee, Tae-Cheon Jeong, Chun-Hwa Kim, Gyu-Sub Ko, Hyun-Woo Ha, Hye Gwang Jeong, Tae Won Jeon, Sangkyu Lee, Mi-Jeong Kang, Jin Woo Yoo, Wonku Kang
Publikováno v:
Biomolecules and Therapeutics. 17:446-454
1-Furan-2-yl-3-pyridin-2-yl-propenone (FPP-3) has recently been synthesized and characterized to have an anti-inflammatory activity through the inhibition of the production of nitric oxide and tumor necrosis factor-. In the present study, adverse eff
Hepatotoxic Effects of 1-Furan-2-yl-3-pyridin-2-yl-propenone, a New Anti-Inflammatory Agent, in Mice
Autor:
Chun Hwa Kim, Tae Won Jeon, Sil Shin, Sangkyu Lee, Tae Cheon Jeong, Mi Jeong Kang, Sang-Hyun Kim, Wonku Kang, Jae Ho Choi, Eung-Seok Lee
Publikováno v:
Biomolecules and Therapeutics. 17:318-324
- 1-Furan-2-yl-3-pyridin-2-yl-propenone (FPP-3) has recently been synthesized and characterized to have an anti-inflammatory activity through the inhibition of the production of nitric oxide. In the present study, adverse effects of FPP-3 on hepati
Publikováno v:
Journal of Korean Sleep Research Society. 5:82-88
Backgraound: The prevalence of sleep disturbance in patients with Alzheimer’s disease (AD) is common. The purpose of this study is whether quality of sleep (QoS) has effect on quality of life (QoL) in Alzheimer’s disease (AD) patients and amnesti